The Biden administration is seeking to limit the availability of certain drugs through telehealth prescriptions, according to a new proposed rule. The proposed rule would require in-person doctor visits for prescriptions of drugs like Adderall and OxyContin.

The proposed rule is part of the Biden administration’s larger effort to combat the opioid epidemic. The rule would require a doctor to physically examine a patient before prescribing drugs like Adderall and OxyContin. It would also limit the amount of time a patient can receive a prescription for a controlled substance through telehealth.

The proposed rule has been met with criticism from some patient advocacy groups, who argue that it could limit access to necessary medications for those in rural areas or with limited mobility.

However, the Biden administration has also proposed a plan to make certain addiction treatments available through telehealth on a permanent basis. This would allow patients to access treatments like medication-assisted therapy without having to physically visit a doctor.

The proposed rule is currently open for public comment and is expected to be finalized later this year. It is part of the Biden administration’s larger effort to combat the opioid epidemic and ensure that patients have access to necessary medications.